-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Sangamo Therapeutics, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Sangamo Therapeutics, Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$37.1M, a 70% increase year-over-year.
- Sangamo Therapeutics, Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$257M, a 19.1% decline year-over-year.
- Sangamo Therapeutics, Inc annual Operating Income (Loss) for 2023 was -$274M, a 36.1% decline from 2022.
- Sangamo Therapeutics, Inc annual Operating Income (Loss) for 2022 was -$201M, a 9.79% decline from 2021.
- Sangamo Therapeutics, Inc annual Operating Income (Loss) for 2021 was -$183M, a 41.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)